Note: This variant has not been sufficiently evaluated by a GET-Evidence editor.
To be considered sufficiently evaluated a variant must have both "variant evidence" and "clinical importance" scores filled in.
Please help improve GET-Evidence by evaluating evidence for this variant!
You are viewing an old version of this page that was saved on December 5, 2010 at 5:09pm by Genome Importing Robot.
Insufficiently evaluated pharmacogenetic
(The "insufficiently evaluated" qualifier is assigned automatically based on the above evidence and importance scores.)
Summary of published research, and additional commentary
Chung JY, Cho JY, Yu KS, Kim JR, Jung HR, Lim KS, Jang IJ, Shin SG. Effect of
the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug
interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther.
2005 Jun;77(6):486-94. PubMed PMID: 15961980.
Added in this revision:
hu43860C - CGI sample GS00253-DNA_A01_200_37
hom C @ chr4:69536084